Prelude Capital Management, LLC Vbi Vaccines Inc Call Options Transaction History

Prelude Capital Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$2.91 - $4.32 $37,539 - $55,728	-12,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $24,940 - $40,600	11,600 Added 892.31%	12,900 $35,000
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $3,601 - $8,021	1,300 New	1,300 $4,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.